Pantoprazole and Reticulocyte count decreased - a phase IV clinical study of FDA data

Summary:

Reticulocyte count decreased is reported as a side effect among people who take Pantoprazole (pantoprazole sodium), especially for people who are female, 60+ old, also take Ventolin, and have Crohn's disease.

The phase IV clinical study analyzes which people have Reticulocyte count decreased when taking Pantoprazole. It is created by eHealthMe based on reports of 281,696 people who have side effects when taking Pantoprazole from the FDA, and is updated regularly.

What is Pantoprazole?

Pantoprazole has active ingredients of pantoprazole sodium. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 285,165 Pantoprazole users. Check the latest studies of Pantoprazole.

What is Reticulocyte count decreased?

Reticulocyte count decreased is found to be associated with 95 drugs and 206 conditions by eHealthMe. Check the latest studies of Reticulocyte count decreased.

On Jul, 29, 2026

281,696 people reported to have side effects when taking Pantoprazole.
Among them, 47 people (0.02%) have Reticulocyte count decreased.

Could Pantoprazole cause Reticulocyte count decreased?

Among these 47 people:

What is the gender of people who have Reticulocyte count decreased when taking Pantoprazole? *

female: 70 %
male: 30 %

What is the age of people who have Reticulocyte count decreased when taking Pantoprazole? *

What are other drugs people take besides Pantoprazole? *

What are other side effects people have besides Reticulocyte count decreased? *

Weakness: 33 people, 70.21%
Red Blood Cell Count Decreased: 31 people, 65.96%
Blood Urea Increased: 29 people, 61.70%
Haematocrit Decreased: 29 people, 61.70%
Haemoglobin Decreased: 29 people, 61.70%
Dizziness: 27 people, 57.45%
Blood Creatinine Increased: 27 people, 57.45%
Joint Pain: 26 people, 55.32%
Hypotension (abnormally low blood pressure): 25 people, 53.19%
Red Blood Cell Elliptocytes Present: 25 people, 53.19%

What are the existing conditions these people have? *

Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 20 people, 42.55%
Venous Thrombosis (blood clot (thrombus) that forms within a vein): 11 people, 23.40%
Joint Pain: 7 people, 14.89%
Hereditary Neuropathic Amyloidosis (hereditary- diseases resulting from abnormal deposition of certain proteins (amyloid) in various bodily areas by problems with signals from the nerves): 5 people, 10.64%
Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 3 people, 6.38%
Oedema Peripheral (superficial swelling): 3 people, 6.38%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 3 people, 6.38%
Thrombosis (formation of a blood clot inside a blood vessel): 2 people, 4.26%
High Blood Pressure: 2 people, 4.26%
Nephrogenic Anaemia (anaemia due to kidney disease): 2 people, 4.26%

* Approximation only. Some reports may have incomplete information.

Do you take Pantoprazole and have Reticulocyte count decreased?

- Check whether Reticulocyte count decreased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Pantoprazole:

Pantoprazole (285,165 reports)

Browse all side effects of Pantoprazole:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Reticulocyte count decreased:

Reticulocyte count decreased (95 drugs)

Browse all the conditions that are associated with Reticulocyte count decreased:

Reticulocyte count decreased (206 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on pantoprazole sodium (the active ingredients of Pantoprazole) and Pantoprazole (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.